Biogen Norway AS is a leading biotechnology company specializing in neurology and rare diseases. The company is known for its pioneering efforts in neuropsychiatry and specialized immunology, and works with the development of innovative treatments for complex diseases. Biogen has a strong focus on research that aims to improve the quality of life for patients.
The company emphasizes sustainability and fairness in the healthcare system, and has a clear commitment to diversity, equality and inclusion in its operations. Biogen Norway AS is motivated by the opportunity to make a difference in the lives of people living with serious health challenges. Through collaboration, they seek to find solutions to challenges in health, and thus contribute to the development of effective treatments.